175 related articles for article (PubMed ID: 32356244)
21. Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis.
Zheng B; Chen Y; Chen Y; Zhao Z; Zhang Z; Zheng J; You Y; Wang Q; Shen L
Retina; 2011 Apr; 31(4):692-701. PubMed ID: 21836401
[TBL] [Abstract][Full Text] [Related]
22. [Is removal of internal limiting membrane always necessary during surgery for refractory diffuse diabetic macular edema without evident epimacular proliferation?].
Aboutable T
Klin Monbl Augenheilkd; 2006 Aug; 223(8):681-6. PubMed ID: 16927225
[TBL] [Abstract][Full Text] [Related]
23. Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.
Yang KB; Zhang H; Li SJ; Cao JJ; Cheng LN; Lin YX; Tian ZC; Li J; Gu F; Liu ZL
J Ocul Pharmacol Ther; 2019 Apr; 35(3):161-167. PubMed ID: 30668279
[TBL] [Abstract][Full Text] [Related]
24. EFFECT OF INTERNAL LIMITING MEMBRANE PEELING DURING VITRECTOMY FOR DIABETIC MACULAR EDEMA: Systematic Review and Meta-analysis.
Nakajima T; Roggia MF; Noda Y; Ueta T
Retina; 2015 Sep; 35(9):1719-25. PubMed ID: 26079478
[TBL] [Abstract][Full Text] [Related]
25. Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study.
Raizada S; Al Kandari J; Al Diab F; Al Sabah K; Kumar N; Mathew S
Indian J Ophthalmol; 2015 Jun; 63(6):504-10. PubMed ID: 26265641
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema].
Khurieva-Sattler E; Krause M; Löw U; Gatzioufas Z; Toropygin S; Seitz B; Ruprecht K; Hille K
Klin Monbl Augenheilkd; 2010 Jun; 227(6):496-500. PubMed ID: 20221984
[TBL] [Abstract][Full Text] [Related]
27. Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy.
Mao JB; Wu HF; Chen YQ; Zhao SX; Tao JW; Zhang Y; Zheng B; Wang L; Shen LJ
Int J Ophthalmol; 2018; 11(7):1217-1221. PubMed ID: 30046542
[TBL] [Abstract][Full Text] [Related]
28. Clinical Efficacy of Preoperative and Intraoperative Intravitreal Ranibizumab as Adjuvant Therapy of Ahmed Glaucoma Valve Implantation Combined with Vitrectomy in the Management of Neovascular Glaucoma with Diabetic Vitreous Hemorrhage.
Gao S; Lin Z; Zhong Y; Shen X
J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248719
[TBL] [Abstract][Full Text] [Related]
29. Vitrectomy with internal limiting membrane peeling versus inverted internal limiting membrane flap technique for macular hole-induced retinal detachment: a systematic review of literature and meta-analysis.
Yuan J; Zhang LL; Lu YJ; Han MY; Yu AH; Cai XJ
BMC Ophthalmol; 2017 Nov; 17(1):219. PubMed ID: 29179705
[TBL] [Abstract][Full Text] [Related]
30. Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Treatment-Naïve Diabetic Macular Edema: A Prospective, Uncontrolled Pilot Study.
Rush RB; Rush SW
Clin Ophthalmol; 2021; 15():2619-2624. PubMed ID: 34188440
[TBL] [Abstract][Full Text] [Related]
31. Pars plana vitrectomy assisted by intravitreal injection of conbercept enhances the therapeutic effect and quality of life in patients with severe proliferative diabetic retinopathy.
Wang Q; Cai H; Xu D; Cui L; Zhang Y; Chen M
Am J Transl Res; 2022; 14(2):1324-1331. PubMed ID: 35273734
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: The VITAL Study.
Iglicki M; Lavaque A; Ozimek M; Negri HP; Okada M; Chhablani J; Busch C; Loewenstein A; Zur D
PLoS One; 2018; 13(7):e0200365. PubMed ID: 29995929
[TBL] [Abstract][Full Text] [Related]
33. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema.
Patel JI; Hykin PG; Schadt M; Luong V; Fitzke F; Gregor ZJ
Retina; 2006 Jan; 26(1):5-13. PubMed ID: 16395132
[TBL] [Abstract][Full Text] [Related]
34. [Effect of internal limiting membrane peeling on morpho-functional state of the retina in patients with proliferative diabetic retinopathy (preliminary report)].
Bikbov MM; Fayzrakhmanov RR; Kalanov MR
Vestn Oftalmol; 2018; 134(1):63-69. PubMed ID: 29543201
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.
Kumar A; Sinha S; Azad R; Sharma YR; Vohra R
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):360-8. PubMed ID: 17093998
[TBL] [Abstract][Full Text] [Related]
36. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling.
Ando F; Yasui O; Hirose H; Ohba N
Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):995-9. PubMed ID: 15592868
[TBL] [Abstract][Full Text] [Related]
37. Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema.
Shimizu N; Oshitari T; Tatsumi T; Takatsuna Y; Arai M; Sato E; Baba T; Yamamoto S
Biomed Res Int; 2017; 2017():1747108. PubMed ID: 28758110
[TBL] [Abstract][Full Text] [Related]
38. Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients.
Kamura Y; Sato Y; Isomae T; Shimada H
Jpn J Ophthalmol; 2005; 49(4):297-300. PubMed ID: 16075329
[TBL] [Abstract][Full Text] [Related]
39. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
Hartley KL; Smiddy WE; Flynn HW; Murray TG
Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
[TBL] [Abstract][Full Text] [Related]
40. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.
Rosenblatt BJ; Shah GK; Sharma S; Bakal J
Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):20-5. PubMed ID: 15290152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
